A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

GlaxoSmithKline has announced a partnership with a UK biotech firm to develop oncology medicines using new methods to fight the …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

